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BACKGROUND: In England, cervical cancer is the second most common cancer in women aged under 35 years. Overall incidence of
cervical cancer has decreased since the introduction of the national screening programme in 1988 but recent trends of incidence in
young women have not been studied in detail.
METHODS: Information on 71511 incident cases of cervical cancer in England, 1982–2006, in 20–79-year-olds was extracted from a
national cancer registration database. Changes in incidence were analysed by age group, time period and birth cohort. Poisson
regression was used to estimate annual percentage change (APC).
RESULTS: Overall incidence, during 1982–2006, fell significantly from 213 to 112 per million person years. However, in 20–29-year-
olds, after an initial fall, incidence increased significantly during 1992–2006, (APC 2.16). In 30–39-year-olds incidence stabilised during
the latter part of the study period. The pattern was most marked in the North East, Yorkshire and the Humber and East Midlands
regions. Birth cohorts that were initially called for screening between 60–64 and 35–39 years of age show an incidence peak
soon after the age of presumed first screen, whereas younger birth cohorts show a peak at about 35 years of age. Incidence in the
1977–1981 birth cohort has increased relative to that among women born between 1962 and 1976.
CONCLUSION: These results have implications for cervical screening, human papilloma virus vaccination and other public health
interventions targeting young people.
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The incidence of cervical cancer in England in 2007 was 8.0 per
100000 females, making it the second most common cancer in
women under 35 (Office for National Statistics, 2010). Cervical
cancer is caused by human papilloma virus (HPV). There are at
least 15 high-risk oncogenic strains of HPV but over 70% of cases
worldwide are associated with strains 16 and/or 18 (Walboomers
et al, 1999; Munoz et al, 2003). The overall prevalence of HPV
infection among women with normal cervical cytology in the UK is
8.9 and 2.4% for HPV 16 and/or 18 (WHO/ICO, 2010). This
infection leads to cervical cancer in a small proportion of infected
women only. Cervical cancer screening has been available in
England since 1967. A formalised national screening programme
was established in 1988 for women aged 20–65 years, but in 2005,
age of first screening invite was raised to 25 years. Screening
uptake and cervical cancer incidence rates have been shown to
vary with age, level of education, affluence and ethnicity (Fouquet
and Gage, 1996; Baker and Middleton, 2003; Sutton and
Rutherford, 2005; Moser et al, 2009; NHS Information Centre,
2009). Overall, the incidence of carcinoma of the cervix has
decreased in England since 1990 secondary to the national
screening programme (Quinn et al, 2001).
Recent trends in incidence of cervical cancer in younger women
have not been studied in detail. Changes in public health
prevention measures, including cervical screening policy and the
introduction of the HPV vaccination programme in 2008 (National
Health Service, 2008), make examining trends essential for disease
control and health commissioning. The present study explores
geographical, socioeconomic and age-related trends in incidence
of cervical cancer from 1982 to 2006 in England, with emphasis on
those aged 20–39 years. The results will provide baseline data for
comparison with future trends following the introduction of HPV
vaccination and have other important implications for public
health policies.
METHODS
Cases of cancer of the cervix diagnosed during the time period
1982–2006 in England were extracted from a database compiled by
the National Cancer Intelligence Centre, Office for National
Statistics (ONS), London. Cases registered from 1982 to 1994 were
coded using the International Classification of Diseases ninth
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yrevision (ICD-9) (World Health Organisation, 1977). The ICD
tenth revision (ICD-10) was used for cases registered from 1995 to
2006 (World Health Organisation, 1992). Data supplied comprised
age in years at diagnosis, year of diagnosis, deprivation index
quintile and Government office Region (GOR).
The deprivation index quintile was calculated as follows.
For each Lower Super Output Area (LSOA) in England, the Index
of Multiple Deprivation (IMD) (Income domain) based on 2001
census data was calculated (Neighbourhood Renewal Unit, 2004).
This measures the proportion of the population in households
in receipt of means tested benefits and thus measures the
proportion of the population suffering from income deprivation.
The index was simplified into quintiles. Each case was allocated to
an LSOA, and so to a deprivation quintile, on the basis of the
postcode of the place of permanent residence at the time of
diagnosis. In order to safeguard anonymity, only the deprivation
quintile, not the actual value of the IMD or the LSOA of residence,
was supplied.
Annual population estimates by single year of age, sex and GOR
were obtained from population estimates unit of the ONS.
Population estimates for 2001 by 5-year age group, LSOA, GOR
and sex were obtained from national census data, as were the
deprivation quintiles of the LSOAs. These populations and patient
counts were used to calculate incidence rates per million person
years (pmpy).
For the analysis of incidence trends, cases were stratified into
5-year age groups, 5-year time periods and, where appropriate, by
GOR. Incidence rates were standardised to the European standard
population using the direct method (Quinn et al, 2005).
Poisson regression was used to estimate the annual percentage
change (APC) and its 95% confidence interval and to examine the
statistical significance of the changes over time in the APC. This
was done by examining the difference in fit between models with a
constant APC over the five periods with a model with a different
trend in the early periods and later periods. To ensure continuity
in the estimate, the time period 1992–1996 was included both as
end and starting point of the two consecutive segments of the
piecewise linear trend.
Age–period–birth cohort analyses of incidence rates were based
on five birth year intervals from 1902–1906 to 1982–1986, with
5-year age groups from 20–24 to 75–79 and 5-year calendar time
periods from 1982–1986 up to 2002–2006 to give matching birth
cohorts, age groups and time periods. The relationships between
age group, birth cohort and time period were estimated using the
method of Clayton and Schifflers (1987a,b), which assumes that
the number of cases in each cohort/age group/period combination
follows a Poisson distribution. The presence of overdispersion was
adjusted for using a quasi-poisson model (McCullagh and Nelder,
1989), where appropriate.
Smoothed incidence rates by single year of age were calculated
by fitting a generalised additive model with penalised regression
splines to the counts (Wood, 2008).
For patients diagnosed from 1997 to 2006, the incidence rates by
deprivation quintile were calculated using the data from the 2001
census. Analysis of the variability in incidence by deprivation was
conducted both nationally and by GOR, again using Poisson
regression.
Statistical analysis was performed using the computer software
SPSS and R (R Development Core Team, 2010). The significance
level was set at 5%.
RESULTS
Tables 1a and b show incidence rates pmpy by age groups and
time period. In all, 71511 cases of cervical cancer were diagnosed
and registered in women aged 20–79 years between 1982 and 2006.
Only 36 cases were recorded in women aged 15–19 years, so no
further analysis was performed in this age group.
Overall incidence of cervical cancer has nearly halved from 1982
to 2006 at an approximate annual rate of  3.2% in the time period
1982–1996 and at a greater rate of  3.9% in the time period
Table 1a Age-standardised incidence rate per million person years at risk and total number of cases (N) of cervical cancer in England by time period and
age group
Age
(years) 1982–1986 1987–1991 1992–1996 1997–2001 2002–2006 1982–2006 N
20–29 63 54 51 54 62 56 4943
30–39 234 245 191 158 159 195 17289
40–49 238 249 185 161 127 188 14965
50–59 231 223 157 123 106 164 11430
60–69 318 277 164 129 102 201 12320
70–79 263 266 222 166 116 208 10564
20–79 213 208 154 128 112 161 71511
Table 1b Estimate of the annual percent change (95% confidence interval) and P-values for constant or different trends in incidence during 1982–2006
P-values APC
Age (years) Trend Trend varies 1982–1996 1992–2006
20–29 0.95 o0.001  2.11 ( 2.93,  1.28) 2.16 (1.29, 3.04)
30–39 o0.001 0.66  2.32 ( 2.74,  1.89)  2.49 ( 2.95,  2.03)
40–49 o0.001 o0.001  2.41 ( 2.87,  1.96)  4.22 ( 4.71,  3.73)
50–59 o0.001 0.15  3.88 ( 4.38,  3.38)  4.58 ( 5.16,  4.00)
60–69 o0.001 0.6  6.01 ( 6.47,  5.55)  5.76 ( 6.37,  5.14)
70–79 o0.001 o0.001  1.50 ( 2.02,  0.97)  6.36 ( 6.97,  5.74)
20–79 o0.001 o0.001  3.19 ( 3.39,  2.99)  3.86 ( 4.09,  3.62)
Abbreviation: APC¼annual percentage change.
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10-year age group showed that incidence rates have declined
continuously in those aged 40–79 years (Po0.001). However, in
contrast to all other groups, incidence of cervical cancer in women
aged 20–29 years declined between 1982 and 1991, but increased
significantly by 2.2% annually between 1992 and 2006. In women
aged 30–39 years incidence decreased between 1987 and 2001 but
there was no further decline after that (Table 1a).
Figure 1 displays these results graphically for three 5-year time
periods. It shows that there is a bimodal distribution in incidence
with age in each period. However, the shape of the curve has
changed over time. The age at maximum incidence of the first peak
has declined from 40 years in the 1982–1986 period to 38 years for
1992–1996 and then to 33 years for 2002–2006. Conversely, the
age at maximum incidence of the second peak has been displaced
towards older ages by more than 10 years. In contrast to the earlier
periods, during 2002–2006 the incidence at the younger age peak
exceeds that at older ages.
When the effect of birth cohort on incidence is considered
(Table 2), it is clear that there are highly significant effects of both
time period and birth cohort on the incidence rate by age group.
Although the age–period–cohort model was significantly better
than any of the simpler models (Po0.001), this model still had
significant overdispersion, implying there were complex interac-
tions between these effects. This can be seen in the plot of
incidence by age for each birth cohort (Figure 2). The earliest and
most recent birth cohorts (1902–1911 and 1982–1986) were
excluded from the plot for clarity. The early birth cohorts (1922–1926
to 1947–1951) all have the same temporal pattern with an initial
peak corresponding to 1988–1990 followed by a rapid decline.
Birth cohorts from 1952–1956 to 1967–1971 all have peaks in
incidence at around 35 years of age although the shape of the curve
and overall incidence levels vary. In the 1972–1976 birth cohort
the incidence rises more steeply after age 32 compared with 1962–
1966 and 1967–1971. The incidence below age 30 in the most
recent birth cohort (1977–1981) is clearly higher than in the birth
cohorts between 1962 and 1976 (Figure 3).
Table 3a shows that there is significant regional variation in the
incidence of cervical cancer for all time periods (Po0.001).
Overall, the highest rate is seen in Yorkshire and the Humber,
followed by North West, North East and West Midlands.
The lowest rate is found in the East of England, followed by the
South East and London GORs. Over the five time periods the three
lowest ranked regions remained the same (London, South East,
East of England). However, trends in incidence varied significantly
by GOR as did the APC during 1982–1996 and 1992–2006, P in
all cases o0.001 (Table 3b). East Midlands increased in rank and
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Figure 1 Smoothed incidence rate (per million person years) of cervical
cancer in England by time period and age.
Table 2 Results of fitting age–period–cohort Poisson regression model
to incidence of cervical cancer
Model
Degrees
of freedom Deviance
P-value
compared
to simpler
model
Simpler
model
Null 119 18690
Age 108 6348 o0.0001 Null
Age+drift 107 4844 o0.0001 Age
Age+period 104 1664 o0.0001 Age+drift
Age+cohort 92 1029 o0.0001 Age+drift
Age+cohort+period 88 601 o0.0001 Age+cohort
Age+cohort+period 88 601 o0.0001 Age+period
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Figure 2 Smoothed incidence rate (per million person years) of cervical cancer in England by birth cohort and age.
Increases in cervical cancer in young women in England
G Foley et al
179
British Journal of Cancer (2011) 105(1), 177–184 & 2011 Cancer Research UK
E
p
i
d
e
m
i
o
l
o
g
ythe North West decreased in rank over the time period of the
study reflecting the low APC ( 1.31) observed in the East
Midlands in 1992–2006 and the respective high APC ( 5.34) in
the North West.
As trends over time among women aged 20–39 years differed
from those aged 40 years and above, further analyses were carried
out in this younger age group. Table 4a shows incidence in 20–29-
year-olds by time period and GOR. In each time period, the rates
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Figure 3 Smoothed incidence rate (per million person years) of cervical cancer in England by selected birth cohort (1957–1981) and age (20–49).
Table 3a Age-standardised incidence rate per million person years at risk and actual number of cases (N) of cervical cancer in England by time period and
region for 20–79-year-olds
GOR 1982–1986 1987–1991 1992–1996 1997–2001 2002–2006 1982–2006 N
North East 224 227 170 155 133 181 4338
North West 251 255 200 152 125 195 12254
Yorkshire and Humber 275 268 190 163 145 206 9279
East Midlands 218 194 137 127 132 159 5901
West Midlands 233 229 177 146 123 180 8451
East of England 164 166 124 91 80 123 5933
London 177 170 138 113 99 138 8534
South East 182 179 127 100 95 135 9630
South West 211 210 134 142 123 162 7191
P-value heterogeneity o0.001 o0.001 o0.001 o0.001 o0.001 o0.001
Abbreviation: GOR¼Government office Region.
Table 3b Estimate of the annual percent change (95% confidence interval) and P-values for constant or different trends in incidence during 1982–2006
P-values APC
GOR Trend Trend varies 1982–1996 1992–2006
North East o0.001 0.27  2.53 ( 3.36,  1.70)  3.42 ( 4.35,  2.47)
North West o0.001 o0.001  2.31 ( 2.80,  1.82)  5.34 ( 5.91,  4.77)
Yorkshire and Humber o0.001 0.91  3.54 ( 4.10,  2.98)  3.60 ( 4.25,  2.95)
East Midlands o0.001 o0.001  4.62 ( 5.32,  3.90)  1.31 ( 2.11,  0.49)
West Midlands o0.001 0.007  2.69 ( 3.28,  2.10)  4.21 ( 4.89,  3.53)
East of England o0.001 o0.001  2.99 ( 3.69,  2.29)  5.31 ( 6.11,  4.50)
London o0.001 0.11  2.59 ( 3.18,  1.99)  3.50 ( 4.17,  2.83)
South East o0.001 0.6  3.63 ( 4.18,  3.08)  3.91 ( 4.55,  3.28)
South West o0.001 0.01  3.89 ( 4.53,  3.24)  2.23 ( 2.96,  1.50)
Trend varies by GOR o0.001 o0.001 o0.001
Abbreviations: APC¼annual percentage change; GOR¼Government office Region.
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rates were identified in the North East and Yorkshire and the
Humber but London had a strikingly low incidence rate. The
trends also varied by GOR (Po0.001). Six out of nine regions
showed an initial decrease followed by an increase. This change
was statistically significant in 5 regions. The exceptions were the
North East, which initially had stable rates followed by a rapid
increase, and the East of England, West Midlands and North West,
which had fairly stable rates throughout (Table 4b). In North East,
Yorkshire and the Humber, East Midlands and South West
incidence rates have increased significantly from 1992 to 2006
with annual increases of 6.0%, 5.1%, 8.5% and 3.2%, respectively.
Table 5a shows incidence in 30–39-year-olds by time period
and GOR. In each time period, the rates varied significantly
between regions and the trend over time varied significantly by
region (Table 5b). The trend during 1982–1996 compared with
1992–2006 was similar in most regions. However, in the
East Midlands there was a significant decline in the first period
but a significant increase during the later period. In the North
West and West Midlands, the initial small decline in rates
accelerated over time. As seen in 20–29-year-olds, the lowest
rates in 30–39-year-olds were seen in London throughout the time
period of the study.
As expected, incidence increased with increasing IMD quintile
in both 20–29 and 30–39 year age groups (P for trend o0.001 in
both age groups). However, when the differences in incidence by
both GOR and deprivation for 20–39-year-olds during the period
1997–2006 (which is the only period for which the IMD was
available) were studied, it was found that the effect of GOR was still
significant (Po0.001) after taking deprivation into account.
DISCUSSION
This is the first study to show that, in 20–29-year-olds from 1996
onwards, incidence of cervical cancer is rising in most regions in
England and incidence rates in women aged 30–39 years have
mainly stabilised. In contrast, incidence has declined markedly in
those aged 40–79 years. These differing trends between age groups
have resulted in a marked change in the shape of the age–
incidence curve for cervical cancer over time, such that the
dominant peak in incidence is now below 40 years of age. Overall,
incidence of cervical cancer in women aged 20–79 years in
England has almost halved from 1982 to 2006. The decline is seen
across all regions of England although there is significant regional
variation in incidence in each time period. The greatest decreases
in incidence rates were seen between 1987 and 1996, following the
introduction of the formalised screening programme in 1988.
The changes to the shape of the age–incidence curve over time
are best explained by a birth cohort effect. The peak age of
incidence occurs progressively earlier in successive 5-year birth
cohorts between 1912–1916 and 1952–1956 and declines from
about 63 years of age to 35 years. Women born before 1923 would
have been too old to be included in the formalised call–recall
screening system. For cohorts born in 1922–1951 peak ages of
incidence correlate with presumed age of first screening invitation,
Table 4a Age-standardised incidence rate per million person years at risk and actual number of cases (N) of cervical cancer in England by time period and
region for 20–29-year-olds
GOR 1982–1986 1987–1991 1992–1996 1997–2001 2002–2006 1982–2006 N
North East 59 57 57 96 103 72 324
North West 59 57 77 52 72 63 752
Yorkshire and Humber 98 64 57 75 88 75 656
East Midlands 78 46 38 65 81 60 423
West Midlands 75 83 76 82 71 78 709
East of England 47 36 50 37 53 44 400
London 40 35 23 32 29 31 524
South East 62 45 46 41 54 49 655
South West 62 79 51 57 81 65 500
P-value
heterogeneity
o0.001 o0.001 o0.001 o0.001 o0.001 o0.001
Abbreviation: GOR¼Government office Region.
Table 4b Estimate of the annual percent change (95% confidence interval) and P-values for constant or different trends in incidence during 1982–2006
P-values APC
GOR Trend Trend varies 1982–1996 1992–2006
North East o0.001 0.09 0.80 ( 2.67, 4.40) 6.04 (2.73, 9.46)
North West 0.21 0.2 1.91 ( 0.26, 4.13)  0.60 ( 2.74, 1.60)
Yorkshire and Humber 0.64 o0.001  5.10 ( 7.28,  2.88) 5.05 (2.57, 7.59)
East Midlands 0.25 o0.001  6.40 ( 9.15,  3.57) 8.48 (5.32, 11.73)
West Midlands 0.76 0.5 0.49 ( 1.69, 2.71)  0.85 ( 3.09, 1.44)
East of England 0.44 0.53  0.29 ( 3.23, 2.74) 1.41 ( 1.55, 4.45)
London 0.01 0.01  4.45 ( 6.89,  1.96) 1.44 ( 1.20, 4.16)
South East 0.12 0.01  3.52 ( 5.70,  1.29) 2.04 ( 0.38, 4.52)
South West 0.53 0.02  2.32 ( 4.89, 0.32) 3.23 (0.50, 6.03)
Trend varies by GOR o0.001 o0.001 o0.001
Abbreviations: APC¼annual percentage change; GOR¼Government office Region.
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year or two of this. Those included in the 1952–1956 birth cohort
would have received their first screening invitation mainly before
age 35 years and age of peak incidence stabilises at 35 years of age
in the cohorts born in 1952–1971. Although, due to insufficient
years of follow-up, it is not possible to determine age or magnitude
of peak incidence in the two youngest cohorts, it is clear
that incidence below age 30 years has increased markedly in the
1977–1981 birth cohort compared with the previous three cohorts
(1972–1976, 1967–1971, 1962–1966) with most of the increase
between ages 25 and 29 years. This youngest cohort was below 30
years of age at the end of the present study period. Whether the
increased incidence of cervical cancer among this cohort of women
will continue as they reach their 30s is not known. However, an
increase in incidence around age 32–35 years is apparent in the
1972–1976 birth cohort corresponding to the same calendar years
as the increase observed in the younger cohort.
Women born in 1977–1981 would have received their first
screening invitation at age 20 years and first recall before 2005
when age of first screening invite was raised to 25 years. Although
cervical screening is very effective in older women, screening is
problematic in women aged less than 25 years with more
unnecessary interventions being performed on lesions that may
resolve (Moscicki, 2005, Moscicki et al, 2004, 2008). Furthermore,
screening in this age group has little or no impact on cervix cancer
incidence rates (Sasieni et al, 2009). Women who are screened at
age 25–29 years and found to have cervical intraepithelial
neoplasia grade 2/3 (CIN2, CIN3) are generally successfully
treated. However, cervical screening coverage is lower in women
aged under 40 years than in those aged 50–64 years. This
difference is particularly marked in the youngest age group.
In 2008, coverage in 25–29-year-olds was 58.6% compared with
82.2% in 50–54-year-olds. In this age group, coverage was nearly
7% higher in 1999 than in 2008, but in 2009 there was an increase
of nearly 3% over the 2008 rate (NHS Information Centre, 2009). It
remains to be seen whether this recent increase in coverage among
25–29-year-olds is maintained but efforts to further increase
screening coverage in young women could help to limit the rising
trend in cervical cancer incidence in this age group.
Human papilloma virus infection is necessary but not sufficient
for development of cervical cancer, and other factors affect risk of
HPV infections progressing to CIN. Human papilloma virus is
sexually transmitted and aspects of sexual behaviour and
reproductive factors affect risk of CIN and invasive cancer. These
include number of sexual partners, age at first intercourse, early
age at first full-term pregnancy and increasing duration of oral
contraceptive use (International Collaboration of Epidemiological
Studies of Cervical Cancer, 2006a, 2007, 2009). In 1998, 26% of UK
female teenagers first had sexual intercourse under 16 years
compared with just 4% in 1964 and sexually transmitted infections
rates in 16–24-year-old women have more than doubled from 1995
to 2001 in the UK (Tripp and Viner, 2005). A recent government
report shows that in 2009, in the UK, the peak age for sexually
transmitted infections (STIs) in women is between 19 and 20 years,
and that one in ten 15–24-year-olds diagnosed with an STI will
become re-infected within a year (Health Protection Agency, 2010).
The developing cervix at puberty and the healing cervix after
delivery or any concomitant STIs pose a higher risk that HPV will
reach the basal layer of the cervical epithelium, predisposing to a
prolonged infection (Bosch et al, 2002).
A significant risk factor for squamous cell carcinoma of the
cervix is tobacco smoking. Risk increases with number of
cigarettes per day and younger age at starting smoking (Interna-
tional Collaboration of Epidemiological Studies of Cervical Cancer,
2006b). In Great Britain, the highest rates of smoking during
2005–2009 were seen in 20–24-year-olds. In this age group 30%
Table 5a Age-standardised incidence rate per million person years at risk and actual number of cases (N) of cervical cancer in England by time period and
region for 30–39-year-olds
GOR 1982–1986 1987–1991 1992–1996 1997–2001 2002–2006 1982–2006 N
North East 262 247 237 202 201 229 1055
North West 247 297 243 164 161 220 2675
Yorkshire and Humber 334 347 240 228 220 271 2392
East Midlands 238 213 175 175 220 203 1505
West Midlands 283 331 255 189 179 244 2272
East of England 178 191 165 116 124 153 1466
London 169 162 131 98 95 127 1828
South East 204 205 153 130 145 165 2349
South West 249 254 178 208 180 212 1747
P-value heterogeneity o0.001 o0.001 o0.001 o0.001 o0.001 o0.001
Abbreviation: GOR¼Government office Region.
Table 5b Estimate of the annual percent change (95% confidence interval) and P-values for constant or different trends in incidence during 1982–2006
P-values APC
GOR Trend Trend varies 1982–1996 1992–2006
North East 0.001 0.81  1.26 ( 2.99, 0.50)  1.65 ( 3.50, 0.23)
North West o0.001 o0.001  0.73 ( 1.79, 0.35)  5.09 ( 6.26,  3.92)
Yorkshire and Humber o0.001 0.17  3.20 ( 4.32,  2.07)  1.71 ( 2.96,  0.45)
East Midlands 0.06 o0.001  3.47 ( 4.94,  1.97) 2.18 (0.61, 3.77)
West Midlands o0.001 0.005  1.39 ( 2.54,  0.23)  4.49 ( 5.75,  3.20)
East of England o0.001 0.12  1.38 ( 2.83, 0.09)  3.51 ( 5.06,  1.92)
London o0.001 0.83  3.07 ( 4.36,  1.77)  3.34 ( 4.73,  1.93)
South East o0.001 0.07  3.23 ( 4.37,  2.08)  1.29 ( 2.54,  0.02)
South West o0.001 0.09  2.75 ( 4.09,  1.38)  0.59 ( 2.03, 0.87)
Trend varies by GOR o0.001 0.001 o0.001
Abbreviations: APC¼annual percentage change; GOR¼Government office Region.
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although there has been a decline at older ages. About 20% of
16–19-year-olds smoke. The highest rates of smoking among
women are found in the Yorkshire and the Humber, North East,
North West and South West GORs (Office for National Statistics,
2010b), regions that also have high rates of cervix cancer. Changes
in risk behaviours including smoking and sexual behaviour in
women born from the 1970s onwards may have contributed to the
rising incidence of cervical cancer in young women.
Previous studies have shown a link between social deprivation
and increased incidence of cervical cancer (Hemminki et al, 2001;
Singh et al, 2004; Shack et al, 2008). Shack et al (2008) examined
socioeconomic variations in the incidence of cervical cancer
between 1998 and 2003 by region and age groups over and under
65 years and concluded that 28% of cervical cancer cases annually
could be prevented if incidence across the country could be
reduced to that seen in the least deprived areas. In the present
study, incidence among 20–39-year-olds in the least deprived
quintile was 70% of that in the most deprived. However, our
results demonstrated that deprivation alone could not explain
the variability in incidence between geographical regions. Social
deprivation may predispose to cervical cancer indirectly via
increased prevalence of smoking, oral contraceptive use and
decreased screening uptake. Geographical variations in incidence
in younger women may be determined, in part, by geographical
variations in smoking and sexual behaviour across deprivation
categories as well as ethnic mix and levels of education (Health
Protection Agency, 2010; Office for National Statistics, 2011).
A recent study has predicted a 76% reduction in lifetime risk of
cervical cancer in 12-year-olds vaccinated against HPV 16 and 18
in the UK (Kohli et al, 2007). Human papilloma virus vaccination
against the oncogenic high-risk strains 16 and 18 was introduced
in England from 2008 for all girls aged 12–13 years. In addition, at
the outset, a catch-up vaccination programme was introduced for
girls up to the age of 18 years (National Health Service, 2008). It
will be at least 10 years before the protective effect of vaccination
has an impact on cervical cancer rates. In the meantime, screening
offers a means of detecting and curing pre-invasive lesions and of
limiting the rising incidence of cervical cancer in young women.
In conclusion, in spite of falling overall incidence rates for
cervical cancer in England, in recent years incidence in young
women under 40 years of age is stable or increasing. Those born
from 1972 onwards appear to be at greater risk. The pattern is
most marked in the North East, Yorkshire and the Humber and
East Midlands GORs, which have higher rates of cervical cancer
generally. These results have implications for implementation of
public health programmes including measures to increase cover-
age of cervical screening, HPV vaccination and other public health
interventions targeting young people such as sexual health
education and tobacco control.
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